Wird geladen...
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
The purpose of this study was to evaluate the efficacy and safety of a novel oral anticancer fluoropyrimidine derivative, S-1, in patients receiving initial chemotherapy for unresectable, advanced non-small-cell lung cancer (NSCLC). Between June 1996 and July 1998, 62 patients with NSCLC who had not...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Nature Publishing Group
2001
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375091/ https://ncbi.nlm.nih.gov/pubmed/11592762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2031 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|